Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5152 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-08 |
filingDate |
2001-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24537aea322512063c072e41a26a0653 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee0ca09390d259a942b2b8477e6c9b94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96619589c3502f443d01661310488f5d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f6c031f63af6086d7ba57f231e940f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd99c23fd242956c07c2833dc9a10dfa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a86af5792ff09f63623abe781071a960 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26fd085c5a1985c9a7b9670153bbb7f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed0f934936c1de4f365849a4cdf5f6d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a91739242355d1db44d45603168ca170 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_151ae1b3b4d1c3f439c76762fbe6de6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7f0b75e848f79920963ff223f8e29d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a0d225cdb54911563f332b5f7780017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81edc3716e403e694de164ea154c0b95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7159ff7dc72ffe3619e6728fe4fc29e |
publicationDate |
2002-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2002141973-A1 |
titleOfInvention |
Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response |
abstract |
The present invention is related to a plurality of dendritic-like cell/tumor cell hybrids which is capable of inducing an anti-tumor response. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8785186-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007212338-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005158244-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009087450-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010047288-A1 |
priorityDate |
1995-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |